CA2129676A1 - Compositions antitussive de dextromethorphane - Google Patents

Compositions antitussive de dextromethorphane

Info

Publication number
CA2129676A1
CA2129676A1 CA 2129676 CA2129676A CA2129676A1 CA 2129676 A1 CA2129676 A1 CA 2129676A1 CA 2129676 CA2129676 CA 2129676 CA 2129676 A CA2129676 A CA 2129676A CA 2129676 A1 CA2129676 A1 CA 2129676A1
Authority
CA
Canada
Prior art keywords
dextromethorphan
antitussive compositions
compositions
dextromethorphan antitussive
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2129676
Other languages
English (en)
Other versions
CA2129676C (fr
Inventor
Ronald Lee Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Ronald Lee Smith
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ronald Lee Smith, The Procter & Gamble Company filed Critical Ronald Lee Smith
Publication of CA2129676A1 publication Critical patent/CA2129676A1/fr
Application granted granted Critical
Publication of CA2129676C publication Critical patent/CA2129676C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
CA002129676A 1990-10-31 1991-10-21 Compositions antitussive de dextromethorphane Expired - Fee Related CA2129676C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60629490A 1990-10-31 1990-10-31
US606,294 1990-10-31

Publications (2)

Publication Number Publication Date
CA2129676A1 true CA2129676A1 (fr) 1992-05-14
CA2129676C CA2129676C (fr) 1997-09-30

Family

ID=24427392

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002129676A Expired - Fee Related CA2129676C (fr) 1990-10-31 1991-10-21 Compositions antitussive de dextromethorphane

Country Status (13)

Country Link
EP (1) EP0555411A1 (fr)
JP (1) JPH06502428A (fr)
AU (1) AU663857B2 (fr)
CA (1) CA2129676C (fr)
CZ (1) CZ79593A3 (fr)
FI (1) FI931934A (fr)
HU (1) HUT64216A (fr)
IE (1) IE913792A1 (fr)
MX (1) MX9101831A (fr)
PL (1) PL168968B1 (fr)
PT (1) PT99380B (fr)
SK (1) SK42593A3 (fr)
WO (1) WO1992007559A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1274026B (it) * 1994-03-01 1997-07-14 Acraf Composizione antitosse
SE9601528D0 (sv) * 1996-04-23 1996-04-23 Pharmacia Ab Transdermally administered dextromethorphan as antitissue agent
US6306843B1 (en) 1997-07-15 2001-10-23 Walter Burghart Method for producing stable acetylsalicylic acid solutions
US6245785B1 (en) * 1998-11-30 2001-06-12 Warner Lambert Company Dissolution of triprolidine hydrochloride
US6846495B2 (en) * 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
DE102007000521A1 (de) 2007-10-18 2009-04-23 Renate Conrad Hustenpräparat
EP3544631A1 (fr) 2016-11-28 2019-10-02 Johnson & Johnson Consumer Inc. Compositions liquides comprenant un agent mucoadhésif

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4294819A (en) * 1980-08-18 1981-10-13 Bristol-Myers Company Alkaline analgesic capsule
US4454140A (en) * 1982-09-07 1984-06-12 Hoffmann-La Roche Inc. Nasal administration of dextromethorphan
US4427681A (en) * 1982-09-16 1984-01-24 Richardson-Vicks, Inc. Thixotropic compositions easily convertible to pourable liquids
US4892877A (en) * 1987-10-27 1990-01-09 Richardson-Vicks Inc. Antitussive liquid compositions containing phenol

Also Published As

Publication number Publication date
HUT64216A (en) 1993-12-28
MX9101831A (es) 1992-06-05
FI931934A0 (fi) 1993-04-29
CA2129676C (fr) 1997-09-30
FI931934A (fi) 1993-05-31
JPH06502428A (ja) 1994-03-17
CZ79593A3 (en) 1994-01-19
PT99380A (pt) 1992-09-30
IE913792A1 (en) 1992-05-22
PT99380B (pt) 1999-04-30
SK42593A3 (en) 1993-09-09
EP0555411A1 (fr) 1993-08-18
WO1992007559A1 (fr) 1992-05-14
PL168968B1 (en) 1996-05-31
HU9301254D0 (en) 1993-07-28
AU8915891A (en) 1992-05-26
AU663857B2 (en) 1995-10-26

Similar Documents

Publication Publication Date Title
ITRM910696A0 (it) Composizioni farmaceutiche per l'applicazione per via nasale.
OA09772A (en) "mometasone furoate monohydrate, process for making same and pharmaceutical compositions".
PH31059A (en) Pharmaceutical compositions comprising cyclosporins.
NZ236581A (en) 3-amino piperidine derivatives, analogues and pharmaceutical compositions
FR2677984B1 (fr) Derives d'imidazoline n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
NZ240378A (en) Substituted thiazolidinedione derivatives; pharmaceutical compositions,
AU5157590A (en) Pharmaceutical compositions for oral administration
CA2101648A1 (fr) Conjugues polysaccharide-proteine
IL99030A0 (en) 1,4-dihydropyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
AU3019292A (en) Pharmaceutical compositions for peroral administration
NZ238088A (en) Quinoline derivatives, preparation and pharmaceutical compositions thereof
CA2129676A1 (fr) Compositions antitussive de dextromethorphane
CA2220019A1 (fr) Composition pharmaceutique contenant de l'hydrochlorure de tiagabine et procede de preparation
AU1252592A (en) Swallowable pharmaceutical compositions
AU1227292A (en) Pharmaceutical antitussive compositions
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
ZA918381B (en) Pharmaceutical compositions.
IL100955A (en) Amino-polyhydroxy- cyclopentane derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
AU8522491A (en) Substituted imidazoles, their preparation and pharmaceutical compositions
NZ237442A (en) 1,6,7,9-tetrahydroxy-11-oxolabdane derivatives; their preparation and pharmaceutical compositions
ZA927369B (en) Pharmaceutical compositions.
EP0300036A4 (fr) Compositions pharmaceutiques a base de vasopressine.
AU8490991A (en) Substituted 2 imidazolone derivatives, their preparation and pharmaceutical compositions
ES8703872A1 (es) Procedimiento para preparar derivados de isoquinolina.
GB9003185D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed